Assessment of myocardial scarring by contrast enhanced magnetic resonance imaging in a patient 11 years after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy

被引:2
|
作者
Butz, T. [1 ,2 ]
Horstkotte, D. [2 ]
Koerfer, J. [3 ]
Langer, C. [2 ]
Seggewiss, H. [4 ]
Faber, L. [2 ]
机构
[1] Ruhr Univ Bochum, Dept Cardiol & Angiol, Marienhosp, D-44627 Herne, Germany
[2] Ruhr Univ Bochum, Dept Cardiol, Heart & Diabet Ctr N Rhine Westphalia, Bad Oeynhausen, Germany
[3] Ruhr Univ Bochum, Inst Radiol Nucl Med & Mol Imaging, Heart & Diabet Ctr N Rhine Westphalia, Bad Oeynhausen, Germany
[4] Leopoldina Hosp Schweinfurt, Schweinfurt, Germany
关键词
Hypertrophic obstructive cardiomyopathy; Septal ablation; PTSMA; Magnetic resonance imaging; MRI; Myocardial scar; VENTRICULAR OUTFLOW TRACT;
D O I
10.1016/j.ijcard.2008.12.096
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report on a 60 year-old male who was one of the first patients who underwent percutaneous transluminal septal myocardial ablation (PTSMA) in our institution in 1996. Contrast enhanced cardiac magnetic resonance imaging (MRI) 11 years after the PTSMA demonstrated extensive scarring, in septal and inferior segments of the left ventricle, and an excellent functional result. It has been previously demonstrated that contrast-enhanced MRI allows detailed evaluation of size and location of septal myocardial infarction induced by PTSMA, and that infarction size detected by MRI correlates well with clinical indexes of infarct size. Our case report underlines the importance of ongoing specialized care and reassessment of patients after PTSMA including continuous clinical risk assessment. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:E3 / E5
页数:3
相关论文
共 50 条
  • [21] Evaluation with Computed Tomography of Percutaneous Transluminal Septal Myocardial Ablation in Hypertrophic Obstructive Cardiomyopathy
    Tanaka, Takamasa
    Okamura, Atsunori
    Nagai, Hiroyuki
    Sumiyoshi, Akinori
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (16) : S265 - S266
  • [22] Intracardiac echocardiography for percutaneous transluminal septal myocardial ablation in the treatment of hypertrophic obstructive cardiomyopathy
    Onishi T.
    Onishi Y.
    Kobayashi I.
    Tachibana K.
    Umezawa S.
    Niwa A.
    Journal of Echocardiography, 2015, 13 (4) : 151 - 152
  • [23] Early left ventricular remodeling after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy
    van Dockum, WG
    Beek, AM
    Ten Cate, F
    Ten Berg, JM
    Gotte, MJW
    Hofman, MBM
    Visser, CA
    Van Rossum, AC
    EUROPEAN HEART JOURNAL, 2004, 25 : 541 - 541
  • [24] Guiding of percutaneous transcoronary septal myocardial ablation in hypertrophic obstructive cardiomyopathy by myocardial contrast echocardiography
    Faber, L
    Seggewiss, H
    Fassbender, D
    Strick, S
    Gleichmann, U
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 1998, 11 (05) : 443 - 448
  • [25] Successful percutaneous transluminal septal myocardial ablation through a right superior septal artery for a patient with hypertrophic obstructive cardiomyopathy
    Kurita T.
    Tsuchikane E.
    Tanaka N.
    Suzuki T.
    Cardiovascular Intervention and Therapeutics, 2015, 30 (4) : 377 - 381
  • [26] Regression of hypertrophy in remote myocardium after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: A magnetic resonance imaging follow-up study
    van Dockum, WG
    Gotte, MJW
    Beek, AM
    ten Cate, FJ
    ten Berg, JM
    Hofman, MBM
    Visser, CA
    van Rossum, AC
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 166A - 166A
  • [27] Disappearance of septal Q waves following percutaneous transluminal septal myocardial ablation for obstructive hypertrophic cardiomyopathy
    Cheng, TO
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (04): : 515 - 516
  • [28] Myocardial perfusion assessed by real time contrast echocardiography in patients with obstructive hypertrophic cardiomyopathy referred for percutaneous transluminal septal myocardial ablation
    Pedone, C
    Biagini, E
    van der Lee, C
    Vletter, WB
    ten Cate, FJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 272A - 272A
  • [29] "Protruding Myocardium" as a Target for Percutaneous Transluminal Septal Myocardial Ablation in a Case of Hypertrophic Obstructive Cardiomyopathy
    Maekawa, Yuichiro
    Akita, Keitaro
    Tsuruta, Hikaru
    Yashima, Fumiaki
    Kimura, Mai
    Yamada, Yoshitake
    Kawakami, Takashi
    Kanazawa, Hideaki
    Hayashida, Kentaro
    Yuasa, Shinsuke
    Murata, Mitsushige
    Jinzaki, Masahiro
    Fukuda, Keiichi
    JACC-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (12) : E201 - E202
  • [30] Changes in vortex and systolic anterior motion after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy
    Shirakura, Satoshi
    Hayama, Hiromasa
    Hara, Hisao
    Kawakami, Yoshihisa
    Doi, Seiichi
    Yoshida, Shigehisa
    Hiroi, Yukio
    JOURNAL OF ECHOCARDIOGRAPHY, 2023, 22 (3) : 171 - 172